THE USE OF TELEMEDICINE TO ASSESS AND ADVISE PATIENTS REGARDING DIETARY TREATMENT OF HYPERPHOSPHATAEMIA

被引:6
|
作者
Kariyawasam, D. [1 ]
机构
[1] Kings Coll Hosp London, Dept Dietet, London, England
关键词
Telemedicine; Diet; Hyperphosphataemia; Haemodialysis; Renal;
D O I
10.1111/j.1755-6686.2005.tb00433.x
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Satellite units have the benefit of being local to patients and easily accessible. The main hospital where the dietitians are based is some distance away from the satellite unit. This has traditionally made it more difficult for the dietitians to assess satellite unit patients other than at set times when all the patients are assessed and advised in one visit. The aim of the telemedicine unit was to make dietary assessment of satellite unit patients easier by reducing travel time and to be more accessible to patients at times when visits by the dietitian were not scheduled. Telemedicine units were linked from the main hospital to the satellite unit. Fourteen patients were assessed and advised via this method and of these patients 8 patients were seen for help with their hyperphosphataemia. Phosphate levels on referral were 2.46 +/- 0.47mmols/l and by the following month after review by the dietitian had decreased to 2.06 +/- 0.43mmols/l (p=0.01) and 1.96 +/- 0.16mmols/l by month 6 (p=0.02). This small study shows that the telemedicine unit is an effective way to assess patients and communicate information. Travel time has been saved and patients have had the benefit of receiving dietary information soon after their raised phosphate result rather than having to wait for the next scheduled visit by the dietitian.
引用
收藏
页码:215 / 218
页数:4
相关论文
共 50 条
  • [1] Dietary phosphate restriction in dialysis patients: A new approach for the treatment of hyperphosphataemia
    Guida, B.
    Piccoli, A.
    Trio, R.
    Laccetti, R.
    Nastasi, A.
    Paglione, A.
    Memoli, A.
    Memoli, B.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2011, 21 (11) : 879 - 884
  • [2] DIETARY TRENDS AND MANAGEMENT OF HYPERPHOSPHATAEMIA AMONG DIALYSIS PATIENTS
    Lindley, Elizabeth
    Cruz Casal, Maria
    Rogers, Susan
    Pancirova, Jitka
    Kernc, Jennifer
    Copley, J. Brian
    Fouque, Denis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 464 - 464
  • [3] Hyperphosphataemia and treatment with sevelamer in haemodialysis patients
    Cizman, B
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 : 47 - 49
  • [4] Gastroenterologists Inconsistently Assess for and Advise Against Tobacco use in Patients With Inflammatory Bowel Disease
    Prakash, Pia
    Varadarajan, Nisha
    Reich, Jason
    Borum, Marie
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S50 - S51
  • [5] How to assess an exposure to pollution in daily practice and advise patients?
    Housset, B.
    REVUE FRANCAISE D ALLERGOLOGIE, 2020, 60 (04): : 199 - 200
  • [6] Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patients
    Locatelli, Francesco
    Dimkovic, Nada
    Spasovski, Goce
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (10) : 1475 - 1488
  • [7] Has Telemedicine come to Fruition? Patients' and Physicians' Perceptions Regarding Telemedicine
    Perron, Noelle Junod
    Mazouri, Sanae
    Luechinger, Robin
    Bajwa, Nadia
    Achab, Sophia
    Hudelson, Patricia
    Dao, Melissa Dominice
    Braillard, Olivia
    PATIENT EDUCATION AND COUNSELING, 2023, 109 : 95 - 95
  • [8] Insight to urology patients' preferences regarding telemedicine
    Ellis, Elizabeth
    Gochenaur, Lauren
    Temkin-Greener, Helena
    Joseph, Jean
    Ajay, Divya
    CANADIAN JOURNAL OF UROLOGY, 2023, 30 (01) : 11438 - 11444
  • [9] Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients
    Albaaj, F
    Hutchison, AJ
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (02) : 319 - 328
  • [10] Use of a Telemedicine Bridge Clinic to Engage Patients in Opioid Use Disorder Treatment
    Lynch, Michael J.
    Houck, Patty
    Meyers, Jessica
    Schuster, James
    Yealy, Donald M.
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (05) : 584 - 587